Aditxt (NASDAQ:ADTX) Major Shareholder Financial Lp Hrt Sells 5,120,480 Shares of Stock

Aditxt, Inc. (NASDAQ:ADTX) major shareholder Financial Lp Hrt sold 5,120,480 shares of the business’s stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $0.02, for a total transaction of $102,409.60. Following the completion of the transaction, the insider owned 2,406,438 shares of the company’s stock, valued at $48,128.76. This represents a 68.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Thursday, June 18th, Financial Lp Hrt acquired 7,340,178 shares of Aditxt stock. The stock was purchased at an average cost of $0.01 per share, for a total transaction of $73,401.78.
• On Tuesday, June 16th, Financial Lp Hrt sold 3,132,480 shares of Aditxt stock. The stock was sold at an average price of $0.01, for a total transaction of $31,324.80.
• On Friday, June 12th, Financial Lp Hrt acquired 4,252,767 shares of Aditxt stock. The shares were purchased at an average price of $0.02 per share, with a total value of $85,055.34.
• On Friday, June 5th, Financial Lp Hrt sold 735,462 shares of Aditxt stock. The shares were sold at an average price of $0.06, for a total transaction of $44,127.72.
• On Thursday, June 4th, Financial Lp Hrt bought 843,622 shares of Aditxt stock. The shares were purchased at an average cost of $0.08 per share, with a total value of $67,489.76.
• On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The shares were sold at an average price of $7.56, for a total transaction of $8,232.84.
• On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The stock was sold at an average price of $7.83, for a total transaction of $1,104.03.
• On Tuesday, April 21st, Financial Lp Hrt purchased 2,700 shares of Aditxt stock. The stock was purchased at an average cost of $8.91 per share, for a total transaction of $24,057.00.
• On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The stock was sold at an average price of $8.10, for a total value of $3,588.30.

Aditxt Trading Down 76.8%

Shares of ADTX opened at $0.01 on Thursday. Aditxt, Inc. has a 12 month low of $0.00 and a 12 month high of $53,451.08. The stock has a fifty day moving average price of $2.90 and a 200-day moving average price of $109.35. The firm has a market cap of $7,929.40, a PE ratio of -0.00 and a beta of 0.84.

Aditxt (NASDAQ:ADTX) last posted its quarterly earnings data on Tuesday, March 31st. The company reported $315,563.31 earnings per share for the quarter. Aditxt had a negative return on equity of 374.60% and a negative net margin of 360,152.50%.

Analysts Set New Price Targets

ADTX has been the topic of a number of research analyst reports. Wall Street Zen upgraded Aditxt to a “sell” rating in a research note on Saturday, May 23rd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aditxt in a research report on Monday, April 20th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.

About Aditxt

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.